The Effects of Chicken Extract and a Peptide Supplement for the Prevention of Cognitive Decline in Non-demented Elderly Adults

  • STATUS
    Recruiting
  • End date
    Dec 1, 2023
  • participants needed
    276
  • sponsor
    Brand's Suntory Asia
Send
Updated on 25 January 2022
See if I qualify
Accepts healthy volunteers

Summary

This trial investigates the effect of a chicken extract supplement and a peptide supplement on cognitive function and potential mechanisms of action of cognitive decline during ageing, among non-demented elderly adults using a three-arm, randomized, placebo-controlled clinical trial design.

Details
Condition Cognitive Decline, Mild Cognitive Impairment, Aging
Treatment Placebo, Chicken extract supplement, Peptide Supplement
Clinical Study IdentifierNCT04555655
SponsorBrand's Suntory Asia
Last Modified on25 January 2022

Eligibility

 Yes No Not Sure

Inclusion Criteria

Male or female at 55 - 75 years of age
Baseline cognition
Normal cognition with feelings of cognitive decline (subjective cognitive decline) OR
Mild cognitive impairment (MCI+) with memory impairment
Agree to participate in the study and provide written informed consent

Exclusion Criteria

Inadequate visual and auditory acuity to allow neuropsychological testing
Significant cerebrovascular disease
History of allergy to chicken meat
Diagnosis of Alzheimer's disease (AD) with dementia or any other dementia
Clinical dementia rating (CDR) score of > 0.5 at screening
Evidence of other neurological, psychiatric or physical illness that can produce cognitive deterioration per investigator's judgment
Inability or unwillingness to undergo PET scan
Current diagnosis or history of alcoholism or substance addiction
Regular use of any medication in the past 6 months that may affect cognitive functioning
Regular use of cognitive enhancing supplements in the past 6 months
Subjects with excessive blood donation or blood drawn prior to baseline
Persons with a history of cardiovascular disease or any other cardiovascular or cerebrovascular diseases which investigators deem unsuitable to participate in the clinical study
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

Accepts healthy volunteers

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name
Edit Delete

Added by • 

 • 

Private

Edit Delete

Reply by • • Private
Edit Delete

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note